CD59 and Alzheimer disease: We previously discovered that CD59 is deficient in the AD brains[7] and believe that this possibly dues to either inflammatory molecules down-regulate complement regulatory proteins or some endogenous enzymatic-like molecules cleave of the GPI-anchored proteins, including CD59[7], which allow complement cascades are activated, leading to sustained activation of glial cells or neuron death or both.